STAAR Surgical (NASDAQ:STAA) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell?

Shares of STAAR Surgical Company (NASDAQ:STAA) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $21.35 and traded as high as $26.78. STAAR Surgical shares last traded at $26.69, with a volume of 1,570,875 shares trading hands.

Analyst Ratings Changes

A number of analysts recently issued reports on STAA shares. Canaccord Genuity Group reissued a “hold” rating and set a $28.00 price objective on shares of STAAR Surgical in a research report on Tuesday. Weiss Ratings reissued a “sell (d)” rating on shares of STAAR Surgical in a research report on Wednesday, October 8th. Stifel Nicolaus set a $28.00 price objective on STAAR Surgical and gave the company a “hold” rating in a research report on Thursday, August 7th. Finally, Mizuho lifted their price objective on STAAR Surgical from $17.00 to $18.00 and gave the company a “neutral” rating in a research report on Wednesday, July 16th. Ten analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $20.67.

STAAR Surgical Stock Up 5.4%

The business has a 50-day simple moving average of $27.18 and a two-hundred day simple moving average of $21.35. The company has a market cap of $1.32 billion, a price-to-earnings ratio of -13.83 and a beta of 0.82.

Institutional Trading of STAAR Surgical

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Linden Thomas Advisory Services LLC lifted its position in shares of STAAR Surgical by 3.0% in the first quarter. Linden Thomas Advisory Services LLC now owns 20,978 shares of the medical instruments supplier’s stock worth $370,000 after buying an additional 603 shares during the last quarter. CWM LLC lifted its position in shares of STAAR Surgical by 74.1% during the 2nd quarter. CWM LLC now owns 1,563 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 665 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of STAAR Surgical by 61.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,856 shares of the medical instruments supplier’s stock worth $50,000 after purchasing an additional 706 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its position in shares of STAAR Surgical by 7.8% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 12,711 shares of the medical instruments supplier’s stock worth $213,000 after purchasing an additional 923 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its position in shares of STAAR Surgical by 4.4% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 22,168 shares of the medical instruments supplier’s stock worth $396,000 after purchasing an additional 934 shares during the last quarter. Institutional investors and hedge funds own 96.70% of the company’s stock.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.